Correlation Between XTL Biopharmaceutica and Orian ShM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XTL Biopharmaceutica and Orian ShM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XTL Biopharmaceutica and Orian ShM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XTL Biopharmaceuticals and Orian ShM, you can compare the effects of market volatilities on XTL Biopharmaceutica and Orian ShM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XTL Biopharmaceutica with a short position of Orian ShM. Check out your portfolio center. Please also check ongoing floating volatility patterns of XTL Biopharmaceutica and Orian ShM.

Diversification Opportunities for XTL Biopharmaceutica and Orian ShM

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between XTL and Orian is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals and Orian ShM in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orian ShM and XTL Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XTL Biopharmaceuticals are associated (or correlated) with Orian ShM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orian ShM has no effect on the direction of XTL Biopharmaceutica i.e., XTL Biopharmaceutica and Orian ShM go up and down completely randomly.

Pair Corralation between XTL Biopharmaceutica and Orian ShM

Assuming the 90 days trading horizon XTL Biopharmaceuticals is expected to under-perform the Orian ShM. In addition to that, XTL Biopharmaceutica is 1.59 times more volatile than Orian ShM. It trades about -0.04 of its total potential returns per unit of risk. Orian ShM is currently generating about 0.09 per unit of volatility. If you would invest  152,594  in Orian ShM on August 28, 2024 and sell it today you would earn a total of  40,806  from holding Orian ShM or generate 26.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy98.94%
ValuesDaily Returns

XTL Biopharmaceuticals  vs.  Orian ShM

 Performance 
       Timeline  
XTL Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTL Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Orian ShM 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Orian ShM are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Orian ShM sustained solid returns over the last few months and may actually be approaching a breakup point.

XTL Biopharmaceutica and Orian ShM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XTL Biopharmaceutica and Orian ShM

The main advantage of trading using opposite XTL Biopharmaceutica and Orian ShM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XTL Biopharmaceutica position performs unexpectedly, Orian ShM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orian ShM will offset losses from the drop in Orian ShM's long position.
The idea behind XTL Biopharmaceuticals and Orian ShM pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments